PhRMA 2014: IP, Research, and Reputation
This article was originally published in RPM Report
Executive Summary
NIH research support, intellectual property protections, and restoring the drug industry’s image moved up on the list of podium priorities at the PhRMA annual meeting in Washington, DC.